pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,009 catalysts · 5,347 phase readout · 2,316 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 21 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,316
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT05253352: Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway

Sponsor: Beth Israel Deaconess Medical Center. Phase: . Conditions: Lymphatic System

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07220252: Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis

Sponsor: TG Therapeutics, Inc.. Phase: PHASE2. Conditions: Relapsing Multiple Sclerosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05269238: Improvement of the Performance of Lumbar Punctures After Training Students With an Augmented Reality SIMulator

Sponsor: University Hospital, Strasbourg, France. Phase: NA. Conditions: Lumbar Puncture

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07440238: Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Septic Arthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07171138: This Study Will Use Real-time Pressure Mapping Technology to Determine Which Positioning Strategies and Devices Exert the Least Amount of Pressure on Peri-operative Burn Patients

Sponsor: Sunnybrook Health Sciences Centre. Phase: NA. Conditions: Hospital Acquired Pressure Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT06870058: A Study of NH280105 in Healthy Adult Participants

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Alzheimer Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT01212055: Apheresis of Patients With Immunodeficiency

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: LAD-1, DOCK8, GATA2 Deficancy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06751355: Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial

Sponsor: Washington University School of Medicine. Phase: . Conditions: Kaposi Sarcoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07359352: Surgical Care And Recovery With Laser Evaluation Trial (SCARLET)

Sponsor: AdventHealth. Phase: NA. Conditions: Post-surgical Scars, Hypertrophic Scars, Scar Appearance Dissatisfaction, Aesthetic Surgical Outcomes, Wound Healing After Body-contouring Surgery

full page →ctgov ↗
›COMPLETEDphase readoutNCT04859543: Pediatric Prospective Personalized Immune and Target Identification Trial

Sponsor: Masaryk University. Phase: NA. Conditions: Central Nervous System Neoplasms, Pediatric Cancer, GEN1 Gene Mutation, Tumor, Brain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06970743: A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

Sponsor: BeOne Medicines. Phase: PHASE3. Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05661643: The Efficacy and Safety of Temozolomide in SDH-deficient GIST

Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Gastrointestinal Stromal Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06855043: Little Lungs Study

Sponsor: University of Wisconsin, Madison. Phase: PHASE1. Conditions: Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT05274243: 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis

Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Rheumatoid Arthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT00200343: Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Hepatitis C

full page →ctgov ↗
›RECRUITINGphase readoutNCT06722508: Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients

Sponsor: University of California, Davis. Phase: NA. Conditions: Head Cancer, Neck Cancer, Sarcopenia, Head and Neck Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07484308: Application and Impact Assessment of Ultrasound Super-Resolution Blood Flow Imaging (URM) in Patients With Renal Failure

Sponsor: Ma Zhe. Phase: NA. Conditions: Kidney Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT06331325: Comparison of Frenotomy and Frenectomy Techniques for Management of High Frenum Attachment in Adults

Sponsor: October University for Modern Sciences and Arts. Phase: NA. Conditions: High Frenum Attachment

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06649825: Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.

Sponsor: Shanghai Zhongshan Hospital. Phase: NA. Conditions: Familial Adenomatous Polyposis (FAP)

full page →ctgov ↗
›TEMPORARILY_NOT_AVAILABLEphase readoutNCT06169176: RAPA-501 Therapy of ALS Expanded Access Protocol

Sponsor: Rapa Therapeutics LLC. Phase: . Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07122089: Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

Sponsor: Center Eugene Marquis. Phase: PHASE2. Conditions: Hepatocellular Carcinoma Non-resectable

full page →ctgov ↗
›COMPLETEDphase readoutNCT05024968: Sintilimab in Cancer of Unknown Primary

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Cancer of Unknown Primary Site

full page →ctgov ↗
›COMPLETEDphase readoutNCT04841668: Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly

Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta. Phase: . Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06768476: CART123 + Ruxolitinib in Relapsed/Refractory AML

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Relapsed AML, Refractory AML

full page →ctgov ↗
›RECRUITINGphase readoutNCT07453576: Effect Of Different Sodium Hypochlorite Concentrations On Intracanal Substance P, CGRP And Opiorphin Levels And Postoperative Pain During Root Canal Retreatment

Sponsor: KEZBAN MELTEM ÇOLAK. Phase: NA. Conditions: Persistent Apical Periodontitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07378618: Evaluation of the Accuracy of Palatal Orthodontic Miniscrew Placement.

Sponsor: University of Roma La Sapienza. Phase: NA. Conditions: Malocclusion, Orthodontic Anchorage Procedures, Orthodontics

full page →ctgov ↗
›RECRUITINGphase readoutNCT07513974: Objective Measurement of the Mechanical Pain Threshold With an Algometer for Predicting Intraoperative Opioid Consumption in Patients Who Will be Operate by Thoracotomy and Sternotomy in Cardiac Surgery

Sponsor: Université Libre de Bruxelles. Phase: NA. Conditions: Cardiac Surgery Subjects

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03741790: Airway Management of Pediatric Patients With Klippel-Feil Syndrome

Sponsor: Boston Children's Hospital. Phase: . Conditions: Klippel-Feil Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07424690: Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation

Sponsor: Karolinska University Hospital. Phase: NA. Conditions: Atrial Fibrillation (AF), Atrial Fibrillation Ablation, Elderly

full page →ctgov ↗
›RECRUITINGphase readoutNCT05538910: Defining Neurobiological Links Between Substance Use and Mental Illness

Sponsor: National Institute on Drug Abuse (NIDA). Phase: NA. Conditions: Major Depressive Disorder, Substance Use Disorder, Normal Physiology

full page →ctgov ↗
›COMPLETEDphase readoutNCT01820910: Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment

Sponsor: International Extranodal Lymphoma Study Group (IELSG). Phase: PHASE2. Conditions: Marginal Zone Lymphoma of Ocular Adnexal

full page →ctgov ↗
›RECRUITINGphase readoutNCT04196413: GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

Sponsor: Stanford University. Phase: PHASE1. Conditions: Glioma of Spinal Cord, Glioma of Brainstem

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03044613: Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE1. Conditions: Gastric Cancer, Esophageal Cancer, GastroEsophageal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07228013: Examining Effects of Active Plant Engagement on College Student Well-Being and Performance

Sponsor: Colorado State University. Phase: NA. Conditions: Perceived Stress, State Anxiety, Intrinsic Goal Orientation, Study Habits, Mood, Sleep Quality, Connectedness to Nature, Extrinsic Goal Orientation

full page →ctgov ↗
›RECRUITINGphase readoutNCT01912313: Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)

Sponsor: KU Leuven. Phase: NA. Conditions: IBS, Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT02027233: Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: NA. Conditions: Severe Acute Respiratory Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07469033: Prevalence of Misophonia in Turkish High School Students

Sponsor: Ondokuz Mayıs University. Phase: . Conditions: Misophonia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07471958: Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: . Conditions: Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07403058: Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction

Sponsor: Axon Therapies, Inc.. Phase: NA. Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05830058: Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Melanoma, Renal Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07430748: REGENFAST vs L-PRF in Periodontal Regeneration

Sponsor: University of Santiago de Compostela. Phase: EARLY_PHASE1. Conditions: Regeneration, Periodontal Defects, Biomaterials

full page →ctgov ↗
›COMPLETEDphase readoutNCT02453048: Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: PHASE1. Conditions: Pertussis, Whooping Cough

full page →ctgov ↗
›RECRUITINGphase readoutNCT07299955: A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers

Sponsor: Biocon Biologics UK PLC. Phase: PHASE1. Conditions: Healthy Male Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT04926285: Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)

Sponsor: University of Illinois at Chicago. Phase: PHASE1. Conditions: Relapsed or Refractory Hematologic Malignancies

full page →ctgov ↗
›RECRUITINGphase readoutNCT07144085: Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

Sponsor: Yi Tian. Phase: PHASE1. Conditions: Tumor, Metastatic Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04649385: BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

Sponsor: BeiGene. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07557485: Randomized Clinical Trial of Endovascular Treatment for Progressive Stroke With Vertebrobasilar Artery Occlusion

Sponsor: Feng Gao. Phase: NA. Conditions: Vertebrobasilar Artery Occlusion, Endovascular Treatment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04578938: Ketamine + Cognitive Training for Suicidality in the Medical Setting

Sponsor: Rebecca Price. Phase: PHASE4. Conditions: Suicide, Attempted

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07558915: A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Sponsor: Genentech, Inc.. Phase: PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07426315: Innovative Methodologies for Neuroplasticity in Developmental Age With the Use of Virtual Reality

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: NA. Conditions: Neurodevelopmental Disorders

full page →ctgov ↗
← prev
page 82 of 161
next →